Beijing Kawin Technology Share-holding Co Ltd (688687) - Total Liabilities
Based on the latest financial reports, Beijing Kawin Technology Share-holding Co Ltd (688687) has total liabilities worth CN¥946.31 Million CNY (≈ $138.47 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688687 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Beijing Kawin Technology Share-holding Co Ltd - Total Liabilities Trend (2009–2025)
This chart illustrates how Beijing Kawin Technology Share-holding Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Beijing Kawin Technology Share-holding C total assets.
Beijing Kawin Technology Share-holding Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Kawin Technology Share-holding Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Menivim The New REIT Ltd
TA:MNRT
|
Israel | ILA2.52 Billion |
|
Shenzhen Longli Technology Co Ltd Class A
SHE:300752
|
China | CN¥1.02 Billion |
|
Nawi Brothers Group Ltd
TA:NAWI
|
Israel | ILA3.88 Billion |
|
Community Healthcare Trust Inc
NYSE:CHCT
|
USA | $589.35 Million |
|
Shanghai Dragon Corp
SHG:600630
|
China | CN¥730.25 Million |
|
Mahindra Holidays & Resorts India Limited
NSE:MHRIL
|
India | Rs102.45 Billion |
|
Plaza Retail REIT
TO:PLZ-UN
|
Canada | CA$716.56 Million |
|
Shape Australia Corporation Ltd
AU:SHA
|
Australia | AU$303.84 Million |
Liability Composition Analysis (2009–2025)
This chart breaks down Beijing Kawin Technology Share-holding Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Beijing Kawin Technology Share-holding C to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Kawin Technology Share-holding Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Kawin Technology Share-holding Co Ltd (2009–2025)
The table below shows the annual total liabilities of Beijing Kawin Technology Share-holding Co Ltd from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.05 Billion ≈ $154.13 Million |
+43.24% |
| 2024-12-31 | CN¥735.33 Million ≈ $107.60 Million |
+10.91% |
| 2023-12-31 | CN¥663.01 Million ≈ $97.02 Million |
+25.59% |
| 2022-12-31 | CN¥527.93 Million ≈ $77.25 Million |
+7.68% |
| 2021-12-31 | CN¥490.27 Million ≈ $71.74 Million |
+53.90% |
| 2020-12-31 | CN¥318.56 Million ≈ $46.62 Million |
+13.50% |
| 2019-12-31 | CN¥280.67 Million ≈ $41.07 Million |
+75.76% |
| 2018-12-31 | CN¥159.69 Million ≈ $23.37 Million |
+43.55% |
| 2017-12-31 | CN¥111.24 Million ≈ $16.28 Million |
-25.53% |
| 2015-12-31 | CN¥149.38 Million ≈ $21.86 Million |
-25.13% |
| 2014-12-31 | CN¥199.51 Million ≈ $29.20 Million |
+9.09% |
| 2013-12-31 | CN¥182.89 Million ≈ $26.76 Million |
+22.74% |
| 2012-12-31 | CN¥149.01 Million ≈ $21.80 Million |
+70.23% |
| 2011-12-31 | CN¥87.53 Million ≈ $12.81 Million |
+21.62% |
| 2010-12-31 | CN¥71.98 Million ≈ $10.53 Million |
+134.85% |
| 2009-12-31 | CN¥30.65 Million ≈ $4.48 Million |
-- |
About Beijing Kawin Technology Share-holding Co Ltd
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhiz… Read more